In an effort to decrease medication non-adherence, AllazoHealth worked with Walgreens to deliver AI-driven interventions to high-risk patients.
With the help of AllazoHealth’s AI engine, organizations such as Walgreens can more effectively approach:
- Patients with the greatest risk of non-adherence who are most likely to be influenced by an intervention;
- The best intervention channels and messaging for each individual; and
- The optimal timing and frequency for those adherence interventions.
Download this case study to learn more about all of the ways this technology can positively impact patients, no matter their vulnerability level.